SARS-CoV
SARS-CoV(SARS冠状病毒)
SARS-CoV (SARS coronavirus) is the virus that causes severe acute respiratory syndrome (SARS). Coronaviruses encode papain-like proteases (PLpro) that are often multifunctional enzymes with protease activity to process the viral replicase polyprotein and deubiquitinating (DUB)/deISGylating activity, which is hypothesized to modify the innate immune response to infection.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) is the epidemic and the challenge. COVID-19 is similar to the CoV circulating in Rhinolophus, with a 98.7% nucleotide similarity to the partial RNA dependent RNA polymerase gene of the bat coronavirus strain BtCoV/4991 and 87.9% nucleotide similarity to bat coronavirus strain bat-SL-CoVZC45 and bat-SL-CoVZXC21. Remdesivir and Chloroquine are promising agents against COVID-19.
SARS-CoV 相关产品(158)
- GA23863Z-Leu-Val-Gly-diazomethylketoneCAS: 119670-30-3纯度: >98.00%
Z-Leu-Val-Gly-diazomethylketone 是一种可渗透细胞且不可逆的半胱氨酸蛋白酶抑制剂。
- GC25863RiamilovirCAS: 123606-06-4
Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV.
- GC32223Remdesivir (GS-5734)CAS: 1809249-37-3纯度: >99.50%
Remdesivir (GS-5734)是一种高效抗病毒药物,对SARS-CoV-2病毒及相关α、β、γ和δ变异株的EC 50 值分别为3.3μM、4.7μM、32μM、3.7μM和9.2μM。
- GC39562SARS-CoV-IN-1CAS: 888958-25-6纯度: >99.50%
SARS-CoV-IN-1 是一种有效的 SARS-CoV 复制抑制剂。在 Vero 细胞中,SARS-CoV-IN-1 抗冠状病毒,EC50 为 4.9 μM。SARS-CoV-IN-1 抑制 P. falciparum 3D7 和 W2 株,IC50 分别为 15.4 和 133.2 nM;IC90 分别为 25.7 和 459.1 nM。具有抗疟和抗病毒活性。
- GC39563SARS-CoV-IN-3CAS: 888958-27-8纯度: >99.00%
SARS-CoV-IN-3 是一种有效的 SARS-CoV 复制抑制剂。在 Vero 细胞中,SARS-CoV-IN-3 抗冠状病毒,EC50 为 3.6 μM。SARS-CoV-IN-3 抑制 P. falciparum 3D7 和 W2 株,IC50 分别为 11.7 和 20.4 nM; IC90 分别为 29.19 和 56 nM。在 MT-4 细胞中,SARS-CoV-IN-3 降低 HIV-1 诱导的细胞病变,EC50 为 10 μM。具有抗疟和抗病毒活性。
- GC39612Imatinib D8CAS: 1092942-82-9
Imatinib D8 (STI571 D8) 是 Imatinib (STI571) 的氘代物。Imatinib 是一种口服生物可用的酪氨酸激酶抑制剂,可选择性抑制 BCR/ABL,v-Abl,PDGFR,c-kit 激酶活性。
- GC39642SARS-CoV-IN-2CAS: 888958-26-7纯度: >98.50%
SARS-CoV-IN-2 是一种有效的 SARS-CoV 复制抑制剂。在 Vero 细胞中,SARS-CoV-IN 1 抗冠状病毒,EC50 为 1.9 μM。SARS-CoV-IN-2 抑制 P. falciparum 3D7 和 W2 株,IC50 分别为 21.5 和 30 nM;IC90 分别为 51.0 和 99.9 nM。在 MT-4 细胞中,SARS-CoV-IN-2 降低 HIV-1 诱导的细胞病变,EC50 为 2.9 μM。具有抗疟和抗病毒活性。
- GC45580Tizoxanide-d4CAS: 1246817-56-0纯度: >99.00%
An internal standard for the quantification of tizoxanide
- GC45885Chloroquine-d5 (phosphate)CAS: 1854126-42-3纯度: >99.00%
An internal standard for the quantification of chloroquine
- GC46903Azithromycin-d3CAS: 163921-65-1纯度: >95.00%
An internal standard for the quantification of azithromycin
- GC46936Boceprevir-d9CAS: 1256751-11-7纯度: >99.00%
An internal standard for the quantification of boceprevir
- GC47445Hydroxychloroquine-d4 (sulfate)CAS: 1854126-45-6纯度: >99.00%
An internal standard for the quantification of hydroxychloroquine
- GC47573Lopinavir-d8CAS: 1322625-54-6纯度: >99.00%
An internal standard for the quantification of lopinavir
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GA23863 | Z-Leu-Val-Gly-diazomethylketone | 119670-30-3 | >98.00% | |
Z-Leu-Val-Gly-diazomethylketone 是一种可渗透细胞且不可逆的半胱氨酸蛋白酶抑制剂。 | ||||
| GC14472 | Aviptadil | 40077-57-4 | - | |
Aviptadil是一种具有28个氨基酸的神经递质,是一种血管活性肠多肽(VIP)类似物,具有有效的血管舒张作用,能够诱导肺血管扩张,抑制血管平滑肌细胞增殖、血小板聚集。 | ||||
| GC18620 | EIDD-1931 | 3258-02-4 | >99.50% | |
A ribonucleoside analog with antiviral activity | ||||
| GC25863 | Riamilovir | 123606-06-4 | - | |
Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV. | ||||
| GC31707 | Chebulagic acid | 23094-71-5 | >98.00% | |
A polyphenol with diverse biological activities | ||||
| GC32223 | Remdesivir (GS-5734) | 1809249-37-3 | >99.50% | |
Remdesivir (GS-5734)是一种高效抗病毒药物,对SARS-CoV-2病毒及相关α、β、γ和δ变异株的EC 50 值分别为3.3μM、4.7μM、32μM、3.7μM和9.2μM。 | ||||
| GC39497 | ML188 | 1417700-13-0 | >98.00% | |
ML188 is a non-covalent SARS-CoV 3CLpro inhibitor with IC50 of 1.5 μM. ML188 has antiviral activity. | ||||
| GC39562 | SARS-CoV-IN-1 | 888958-25-6 | >99.50% | |
SARS-CoV-IN-1 是一种有效的 SARS-CoV 复制抑制剂。在 Vero 细胞中,SARS-CoV-IN-1 抗冠状病毒,EC50 为 4.9 μM。SARS-CoV-IN-1 抑制 P. falciparum 3D7 和 W2 株,IC50 分别为 15.4 和 133.2 nM;IC90 分别为 25.7 和 459.1 nM。具有抗疟和抗病毒活性。 | ||||
| GC39563 | SARS-CoV-IN-3 | 888958-27-8 | >99.00% | |
SARS-CoV-IN-3 是一种有效的 SARS-CoV 复制抑制剂。在 Vero 细胞中,SARS-CoV-IN-3 抗冠状病毒,EC50 为 3.6 μM。SARS-CoV-IN-3 抑制 P. falciparum 3D7 和 W2 株,IC50 分别为 11.7 和 20.4 nM; IC90 分别为 29.19 和 56 nM。在 MT-4 细胞中,SARS-CoV-IN-3 降低 HIV-1 诱导的细胞病变,EC50 为 10 μM。具有抗疟和抗病毒活性。 | ||||
| GC39612 | Imatinib D8 | 1092942-82-9 | - | |
Imatinib D8 (STI571 D8) 是 Imatinib (STI571) 的氘代物。Imatinib 是一种口服生物可用的酪氨酸激酶抑制剂,可选择性抑制 BCR/ABL,v-Abl,PDGFR,c-kit 激酶活性。 | ||||
| GC39642 | SARS-CoV-IN-2 | 888958-26-7 | >98.50% | |
SARS-CoV-IN-2 是一种有效的 SARS-CoV 复制抑制剂。在 Vero 细胞中,SARS-CoV-IN 1 抗冠状病毒,EC50 为 1.9 μM。SARS-CoV-IN-2 抑制 P. falciparum 3D7 和 W2 株,IC50 分别为 21.5 和 30 nM;IC90 分别为 51.0 和 99.9 nM。在 MT-4 细胞中,SARS-CoV-IN-2 降低 HIV-1 诱导的细胞病变,EC50 为 2.9 μM。具有抗疟和抗病毒活性。 | ||||
| GC40559 | (±)-Alliin | 17795-26-5 | >98.00% | |
The cysteine sulfoxide constituent of garlic | ||||
| GC40560 | (+)-Alliin | 556-27-4 | >98.00% | |
The cysteine sulfoxide constituent of garlic | ||||
| GC43925 | Ivermectin B1b | 70209-81-3 | >95.00% | |
An anthelmintic | ||||
| GC45580 | Tizoxanide-d4 | 1246817-56-0 | >99.00% | |
An internal standard for the quantification of tizoxanide | ||||
| GC45885 | Chloroquine-d5 (phosphate) | 1854126-42-3 | >99.00% | |
An internal standard for the quantification of chloroquine | ||||
| GC46903 | Azithromycin-d3 | 163921-65-1 | >95.00% | |
An internal standard for the quantification of azithromycin | ||||
| GC46936 | Boceprevir-d9 | 1256751-11-7 | >99.00% | |
An internal standard for the quantification of boceprevir | ||||
| GC47445 | Hydroxychloroquine-d4 (sulfate) | 1854126-45-6 | >99.00% | |
An internal standard for the quantification of hydroxychloroquine | ||||
| GC47573 | Lopinavir-d8 | 1322625-54-6 | >99.00% | |
An internal standard for the quantification of lopinavir | ||||
| GC47707 | MPro Inhibitor 11a | 2103278-86-8 | >95.00% | |
An inhibitor of SARS-CoV-2 M pro | ||||
| GC47708 | MPro Inhibitor 11b | 2413716-71-7 | >98.00% | |
An inhibitor of SARS-CoV-2 M pro | ||||
| GC50483 | TH 1217 | 1862212-48-3 | - | |
TH 1217 (ZINC1775962367) 是一种有效的选择性 dCTPase pyrophosphatase 1 (dCTPase) 抑制剂,IC50 为 47 nM。 | ||||
| GC50727 | MPro 13b | 2412965-59-2 | >97.00% | |
MPro 13b 是一种有效的 Mpro 抑制剂。 | ||||
